|
GRB2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.835760E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.628800E-01 |
| Normal-vs-Stage2 |
5.626400E-01 |
| Normal-vs-Stage3 |
1.121650E-01 |
| Normal-vs-Stage4 |
1.885610E-02 |
| Stage1-vs-Stage2 |
8.568800E-01 |
| Stage1-vs-Stage3 |
3.096800E-01 |
| Stage1-vs-Stage4 |
6.274200E-02 |
| Stage2-vs-Stage3 |
3.901800E-01 |
| Stage2-vs-Stage4 |
1.037040E-01 |
| Stage3-vs-Stage4 |
3.098800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.569800E-01 |
| Normal-vs-AfricanAmerican |
9.159400E-01 |
| Normal-vs-Asian |
2.675600E-01 |
| Caucasian-vs-AfricanAmerican |
4.833600E-01 |
| Caucasian-vs-Asian |
7.914200E-01 |
| AfricanAmerican-vs-Asian |
4.118200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.060400E-01 |
| Normal-vs-Female |
2.535600E-01 |
| Male-vs-Female |
3.966200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.370400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.263010E-01 |
| Normal-vs-Age(61-80Yrs) |
7.083800E-02 |
| Normal-vs-Age(81-100Yrs) |
6.948600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.485200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.484210E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.314000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.835600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.827600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.153400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.069750E-01 |
| Classical-VS-Follicular |
3.440700E-04 |
| Classical-VS-Other |
1.216200E-01 |
| Classical-VS-Normal |
6.911200E-01 |
| Tall-VS-Follicular |
5.214400E-01 |
| Tall-VS-Other |
5.127000E-01 |
| Tall-VS-Normal |
9.155900E-02 |
| Follicular-VS-Other |
7.768800E-01 |
| Follicular-VS-Normal |
6.823800E-03 |
| Other-VS-Normal |
9.444400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.604400E-01 |
| Normal-vs-N1 |
9.973000E-04 |
| N0-vs-N1 |
4.782000E-03 |
|
|
